-
1
-
-
79955653216
-
Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease
-
Brewer H.B. Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease. JClin Endocrinol Metab 2011, 96:1246-1257.
-
(2011)
JClin Endocrinol Metab
, vol.96
, pp. 1246-1257
-
-
Brewer, H.B.1
-
2
-
-
77953852336
-
Anti-oxidant properties of high-density lipoprotein and atherosclerosis
-
Podrez E.A. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol 2010, 37:719-725.
-
(2010)
Clin Exp Pharmacol Physiol
, vol.37
, pp. 719-725
-
-
Podrez, E.A.1
-
3
-
-
0037162038
-
Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
-
Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?. Biochim Biophys Acta 2002, 1582:132-137.
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 132-137
-
-
Okajima, F.1
-
4
-
-
64849106325
-
Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin
-
Rodriguez C., Gonzalez-Diez M., Badimon L., et al. Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb Haemost 2009, 101:665-673.
-
(2009)
Thromb Haemost
, vol.101
, pp. 665-673
-
-
Rodriguez, C.1
Gonzalez-Diez, M.2
Badimon, L.3
-
5
-
-
33644916646
-
Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases
-
Yatomi Y. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr Pharm Des 2006, 12:575-587.
-
(2006)
Curr Pharm Des
, vol.12
, pp. 575-587
-
-
Yatomi, Y.1
-
6
-
-
0035943594
-
Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells
-
Kimura T., Sato K., Kuwabara A., et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. JBiol Chem 2001, 276:31780-31785.
-
(2001)
JBiol Chem
, vol.276
, pp. 31780-31785
-
-
Kimura, T.1
Sato, K.2
Kuwabara, A.3
-
7
-
-
33846016241
-
Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells
-
Kimura T., Tomura H., Mogi C., et al. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. JBiol Chem 2006, 281:37457-37467.
-
(2006)
JBiol Chem
, vol.281
, pp. 37457-37467
-
-
Kimura, T.1
Tomura, H.2
Mogi, C.3
-
8
-
-
79955677017
-
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
-
Argraves K.M., Sethi A.A., Gazzolo P.J., et al. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis 2011, 10:70.
-
(2011)
Lipids Health Dis
, vol.10
, pp. 70
-
-
Argraves, K.M.1
Sethi, A.A.2
Gazzolo, P.J.3
-
9
-
-
78649318696
-
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
-
Sattler K.J., Elbasan S., Keul P., et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010, 105:821-832.
-
(2010)
Basic Res Cardiol
, vol.105
, pp. 821-832
-
-
Sattler, K.J.1
Elbasan, S.2
Keul, P.3
-
10
-
-
0029052921
-
Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets
-
Yatomi Y., Ruan F., Hakomori S., et al. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995, 86:193-202.
-
(1995)
Blood
, vol.86
, pp. 193-202
-
-
Yatomi, Y.1
Ruan, F.2
Hakomori, S.3
-
11
-
-
40749087537
-
Plasma sphingosine 1-phosphate metabolism and analysis
-
Yatomi Y. Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 2008, 1780:606-611.
-
(2008)
Biochim Biophys Acta
, vol.1780
, pp. 606-611
-
-
Yatomi, Y.1
-
12
-
-
41449112571
-
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate
-
Venkataraman K., Lee Y.M., Michaud J., et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008, 102:669-676.
-
(2008)
Circ Res
, vol.102
, pp. 669-676
-
-
Venkataraman, K.1
Lee, Y.M.2
Michaud, J.3
-
13
-
-
84859727262
-
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice
-
Fukuhara S., Simmons S., Kawamura S., et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. JClin Invest 2012, 122:1416-1426.
-
(2012)
JClin Invest
, vol.122
, pp. 1416-1426
-
-
Fukuhara, S.1
Simmons, S.2
Kawamura, S.3
-
14
-
-
52449129893
-
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production
-
Tolle M., Pawlak A., Schuchardt M., et al. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 2008, 28:1542-1548.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1542-1548
-
-
Tolle, M.1
Pawlak, A.2
Schuchardt, M.3
-
15
-
-
0039136346
-
Anovel human apolipoprotein (apoM)
-
Xu N., Dahlback B. Anovel human apolipoprotein (apoM). JBiol Chem 1999, 274:31286-31290.
-
(1999)
JBiol Chem
, vol.274
, pp. 31286-31290
-
-
Xu, N.1
Dahlback, B.2
-
16
-
-
17644393111
-
Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
-
Wolfrum C., Poy M.N., Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 2005, 11:418-422.
-
(2005)
Nat Med
, vol.11
, pp. 418-422
-
-
Wolfrum, C.1
Poy, M.N.2
Stoffel, M.3
-
17
-
-
38349149516
-
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice
-
Christoffersen C., Jauhiainen M., Moser M., et al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. JBiol Chem 2008, 283:1839-1847.
-
(2008)
JBiol Chem
, vol.283
, pp. 1839-1847
-
-
Christoffersen, C.1
Jauhiainen, M.2
Moser, M.3
-
18
-
-
79959340773
-
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
-
Christoffersen C., Obinata H., Kumaraswamy S.B., et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A 2011, 108:9613-9618.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 9613-9618
-
-
Christoffersen, C.1
Obinata, H.2
Kumaraswamy, S.B.3
-
19
-
-
77957324510
-
Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry
-
Lan T., Bi H., Xu S., et al. Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2010, 24:1075-1083.
-
(2010)
Biomed Chromatogr
, vol.24
, pp. 1075-1083
-
-
Lan, T.1
Bi, H.2
Xu, S.3
-
20
-
-
0030054341
-
N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets
-
Yatomi Y., Ruan F., Megidish T., et al. N, N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 1996, 35:626-633.
-
(1996)
Biochemistry
, vol.35
, pp. 626-633
-
-
Yatomi, Y.1
Ruan, F.2
Megidish, T.3
-
21
-
-
23344453368
-
Sphingosine 1-phosphate-related metabolism in the blood vessel
-
Aoki S., Yatomi Y., Ohta M., et al. Sphingosine 1-phosphate-related metabolism in the blood vessel. JBiochem 2005, 138:47-55.
-
(2005)
JBiochem
, vol.138
, pp. 47-55
-
-
Aoki, S.1
Yatomi, Y.2
Ohta, M.3
-
22
-
-
67650479301
-
Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I
-
Okajima F., Sato K., Kimura T. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. Endocr J 2009, 56:317-334.
-
(2009)
Endocr J
, vol.56
, pp. 317-334
-
-
Okajima, F.1
Sato, K.2
Kimura, T.3
-
23
-
-
34247379074
-
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
-
Pappu R., Schwab S.R., Cornelissen I., et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316:295-298.
-
(2007)
Science
, vol.316
, pp. 295-298
-
-
Pappu, R.1
Schwab, S.R.2
Cornelissen, I.3
-
24
-
-
66349139391
-
Lipid phosphate phosphatases and signaling
-
Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. JLipid Res 2009, 50(Suppl):S225-S230.
-
(2009)
JLipid Res
, vol.50
, Issue.SUPPL.
-
-
Brindley, D.N.1
Pilquil, C.2
-
25
-
-
0037162091
-
Roles for lipid phosphate phosphatases in regulation of cellular signaling
-
Sciorra V.A., Morris A.J. Roles for lipid phosphate phosphatases in regulation of cellular signaling. Biochim Biophys Acta 2002, 1582:45-51.
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 45-51
-
-
Sciorra, V.A.1
Morris, A.J.2
-
26
-
-
70349813797
-
Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M
-
Sevvana M., Ahnstrom J., Egerer-Sieber C., et al. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. JMol Biol 2009, 393:920-936.
-
(2009)
JMol Biol
, vol.393
, pp. 920-936
-
-
Sevvana, M.1
Ahnstrom, J.2
Egerer-Sieber, C.3
-
27
-
-
58849083220
-
The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors
-
Kawahara A., Nishi T., Hisano Y., et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 2009, 323:524-527.
-
(2009)
Science
, vol.323
, pp. 524-527
-
-
Kawahara, A.1
Nishi, T.2
Hisano, Y.3
-
28
-
-
3042651483
-
Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions
-
Bhat S., Zabalawi M., Willingham M.C., et al. Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions. JLipid Res 2004, 45:1207-1220.
-
(2004)
JLipid Res
, vol.45
, pp. 1207-1220
-
-
Bhat, S.1
Zabalawi, M.2
Willingham, M.C.3
-
29
-
-
0032775582
-
Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction
-
Waggoner D.W., Xu J., Singh I., et al. Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim Biophys Acta 1999, 1439:299-316.
-
(1999)
Biochim Biophys Acta
, vol.1439
, pp. 299-316
-
-
Waggoner, D.W.1
Xu, J.2
Singh, I.3
-
30
-
-
77950460108
-
Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C
-
Ikeda H., Ohkawa R., Watanabe N., et al. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clin Chim Acta 2010, 411:765-770.
-
(2010)
Clin Chim Acta
, vol.411
, pp. 765-770
-
-
Ikeda, H.1
Ohkawa, R.2
Watanabe, N.3
|